Log In
BCIQ
Print this Print this
 

CMV eVLP (VBI-1501A)

  Manage Alerts
Collapse Summary General Information
Company VBI Vaccines Inc.
DescriptionVaccine based on VBI's enveloped virus-like particle (eVLP) platform
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: Viral vaccine
Latest Stage of DevelopmentPhase I
Standard IndicationCytomegalovirus (CMV)
Indication DetailsPrevent cytomegalovirus (CMV) infection
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

05/09/2016

Undisclosed

Undisclosed

Undisclosed

09/19/2011

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today